The Long-Term Care Community Coalition (LTCCC) submitted the report last week as an update to a 2015 look at anti-psychotic use in nursing homes, finding little change since the non-profit last tackled the subject, according to Skilled Nursing News.
Richard Mollot, executive director of the LTCCC, told Skilled Nursing News that in some cases, facilities are increasing the use of other drugs in place of anti-psychotics and diagnosing residents with schizophrenia later in life.
“You don’t come down with that in your 90s,” he said. “This is something we were always afraid of, that people would start getting diagnoses for the first time in their 80s or 90s of schizophrenia so they could be given the drugs with relative impunity.”
The report comes after Human Rights Watch released its own commentary in February estimating that more than 179,000 people in U.S. nursing facilities are inappropriately given anti-psychotic drugs. The skilled nursing industry pushed back against the report at the time, but the report to the U.N. from the LTCCC said the progress touted by both the industry and by the U.S. government may be overstated.
The Centers for Medicare & Medicaid Services (CMS) began a campaign to improve dementia care in nursing homes in 2012 that had an initial goal of reducing the rate of anti-psychotic drug use by 15% in nine months, or the end of the 2012 calendar year, the LTCCC update said.
Read the full story at Skilled Nursing News.
The Memory Care Forums connect key professionals so that they may share best practices, field research, and practical solutions for improving quality memory care. Hands-on approaches, train-the-trainer sessions, experiential demonstrations, and rich discussions are at the core of each Memory Care Forum.